Leukemia-free survival as a surrogate end point for overall survival in the evaluation of maintenance therapy for patients with acute myeloid leukemia in complete remission. [electronic resource]
Producer: 20111207Description: 1106-12 p. digitalISSN:- 1592-8721
- Antineoplastic Agents -- therapeutic use
- Biomarkers
- Disease-Free Survival
- Histamine -- therapeutic use
- Humans
- Immunotherapy
- Interleukin-2 -- administration & dosage
- Kaplan-Meier Estimate
- Leukemia, Myeloid, Acute -- drug therapy
- Maintenance Chemotherapy
- Remission Induction
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.